Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175967 · ClinicalTrials.gov registry record
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- 11
- Enrollment target
NCT01175967: Clinical Trial study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01175967 is a clinical trial that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01175967 was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
RATIONALE: Measuring changes in performance status and symptoms distress in patients with cancer may help doctors predict how patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This clinical trial is studying changes in performance status and symptoms distress in older patients with advanced ovarian epithelial cancer undergoing surgery and/or chemotherapy.
Primary Outcome
Results will be described by scoring outcome from a professional assessment of performance status as measured by PPSv2, and from a SDS survey which asks about the perceived level of symptom distress the patient is experiencing.PPSv2 is arrayed on a scaled from 10 (bedbound) to 100 (full ambulation) at 10 points increment. A 13-item scale of SDS is used to indicate the degree of distress for a given symptom on a 5 point Likert Scale, ranging from 1 (least amount of distress) to 5 (extreme distres
Interventions
- OTHER Palliative Performance Scale version 2 (PPSv2)
- OTHER McCorkle Symptom Distress Scale (SDS)
- OTHER Geriatric Assessment
- OTHER Medical Records Abstraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-05 |
Why NCT01175967 stopped before completion
NCT01175967 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Palliative Performance Scale version 2 (PPSv2) is the first listed.
NCT01175967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01175967 about?
NCT01175967 is a clinical study titled "Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer". RATIONALE: Measuring changes in performance status and symptoms distress in patients with cancer may help doctors predict how patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This clinical trial is studying changes in performance status and symptoms distr...
What is the current status of trial NCT01175967?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2010-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01175967?
The interventions under investigation include: Palliative Performance Scale version 2 (PPSv2) (OTHER), McCorkle Symptom Distress Scale (SDS) (OTHER), Geriatric Assessment (OTHER), Medical Records Abstraction (OTHER).
Who is sponsoring clinical trial NCT01175967?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia